SMARCB1 and synovial sarcoma: In synovial sarcoma a fusion of a SWI/SNF subunit (SS18) to SSX leads to the eviction of SNF5 from the complex and mis-localization of SWI/SNF ultimately resulting in inappropriate activation of a proliferative transcriptional program [43].